Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
MedPlus Health Services Ltd. ( (IN:MEDPLUS) ) just unveiled an announcement.
MedPlus Health Services Ltd. has announced that its subsidiary, Optival Health Solutions Private Limited, received a suspension order for a Drug License at a store in Maharashtra. This suspension, issued by the Food & Drug Administration in Nagpur, is due to alleged violations under the Drugs and Cosmetics Act, 1940, and is expected to result in a potential revenue loss of approximately Rs 4.34 lacs. The suspension highlights regulatory challenges and could impact the company’s financial operations and market positioning in the region.
More about MedPlus Health Services Ltd.
MedPlus Health Services Ltd. operates in the healthcare industry, primarily focusing on retail pharmacy services. The company is known for its wide network of pharmacy stores across India, providing a range of pharmaceutical and healthcare products.
Average Trading Volume: 21,010
Technical Sentiment Signal: Sell
Current Market Cap: 91.41B INR
See more data about MEDPLUS stock on TipRanks’ Stock Analysis page.